Novel Agents for Acute Myeloid Leukemia.

Cancers (Basel) · 2018 · PMC6267447 · PMID 30423907

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Both trials showed a trend toward higher response rates in the CPX-351 groups compared to control groups, but no differences in term of survival.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.